Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.57M | 17.50M | 74.12M | 72.11M | 16.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.57M | 17.50M | 74.12M | 72.11M | 16.12M |
| Cost of Revenue | 3.11M | 1.21M | 56.29M | 43.28M | 3.39M |
| Gross Profit | 17.47M | 16.29M | 17.84M | 28.83M | 12.73M |
| SG&A Expenses | 19.72M | 19.04M | 49.57M | 23.54M | 16.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.61M | -3.28M | -1.44M | -903.00K | -1.10M |
| Total Operating Expenses | 21.22M | 16.97M | 104.42M | 65.92M | 19.28M |
| Operating Income | -646.00K | 524.00K | -30.30M | 6.20M | -3.16M |
| Income Before Tax | 26.99M | 10.49M | 37.04M | 41.35M | 41.29M |
| Income Tax Expenses | -17.14M | 4.36M | 6.28M | 6.89M | -909.00K |
| Earnings from Continuing Operations | 44.14M | 6.14M | 30.76M | 34.46M | 42.20M |
| Earnings from Discontinued Operations | -- | 46.66M | -- | -- | 12.01M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.14M | 52.80M | 30.76M | 34.46M | 54.21M |
| EBIT | -646.00K | 524.00K | -30.30M | 6.20M | -3.16M |
| EBITDA | 1.12M | 2.03M | -20.43M | 10.12M | -992.00K |
| EPS Basic | 0.09 | 0.11 | 0.07 | 0.07 | 0.12 |
| Normalized Basic EPS | 0.03 | 0.01 | 0.02 | 0.05 | 0.06 |
| EPS Diluted | 0.09 | 0.11 | 0.07 | 0.07 | 0.12 |
| Normalized Diluted EPS | 0.03 | 0.01 | 0.02 | 0.05 | 0.06 |
| Average Basic Shares Outstanding | 490.39M | 466.63M | 439.41M | 492.24M | 451.78M |
| Average Diluted Shares Outstanding | 490.39M | 466.63M | 439.41M | 492.24M | 451.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |